Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.



<ul>
<li>Mizuho analyst Salim Syed initiated coverage on Sutro Biopharma Inc (NASDAQ:STRO) with an Outperform rating and announced a price target of $50. Sutro Biopharma shares closed at $35.39 on Wednesday. See how other analysts view this stock.</li>



<li>Oppenheimer analyst Param Singh initiated coverage on Palantir Technologies Inc (NASDAQ:PLTR) with an Outperform rating and announced a price target of $200. Palantir shares closed at $137.97 on Wednesday. See how other analysts view this stock.</li>
</ul>



Considering buying PLTR stock? Here’s what analysts think: 



<figure class="wp-block-image size-large is-resized"><img width="1024" height="182" src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30091720/image-723-1024x182.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/30091720/image-723-1024x182.png"/></figure>



Photo via Shutterstock

PLTR

STRO

PLTW

Top analysts have initiated coverage on Sutro Biopharma Inc (NASDAQ:STRO) with an Outperform rating and a price target of $50, while Palantir Technologies Inc (NASDAQ:PLTR) also received an Outperform rating with a price target of $200. Sutro shares closed at $35.39, and Palantir shares closed at $137.97 on Wednesday. For a complete view of all analyst rating changes, including upgrades and downgrades, visit the analyst ratings page.

- Mizuho analyst Salim Syed initiated coverage on Sutro Biopharma Inc with an Outperform rating and a price target of $50.  
- Oppenheimer analyst Param Singh initiated coverage on Palantir Technologies Inc with an Outperform rating and a price target of $200.  
- Both stocks closed at significantly lower prices on Wednesday, with Sutro at $35.39 and Palantir at $137.97.

benzinga_article

Palantir Tech

Sutro Biopharma

Roundhill PLTR WeeklyPay ETF

Leverage Shares 2x Cpd Acclrtd PLTRMnETF

VanEck Biotech ETF

SPDR S&P Biotech

Defiance Leveraged Long +Income PLTR ETF

Proshares Big Data Refiners ETF

Direxion Daily PLTR Bull 2X Shares

Leverage Shares 2X Long PLTR Daily ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

GraniteShares 2x Long PLTR Daily ETF

Franklin Exponential Data ETF

Mizuho Financial

Mizuho Financial Group, Inc.

Oppenheimer

This Palantir Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday